.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Bruce Voss
Bruce VossLHA Investor Relations

Bruce Voss

Managing Director at LHA Investor Relations

PR Consultant

Deal Bio

Total Deals5
Valued Deals5
Total Value£1,477M
Avg. Deal Size£295M

Expertise (5)

Key Relationships

United States
Biotechnology
MajorityPrivateAcquisition
Initio Biotherapeutics

target

Initio Biotherapeutics

Ligand Pharmaceuticals

bidder

Ligand Pharmaceuticals

£9m

4 dealmakers

United States
Biotechnology
DomesticPublicAcquisitionTender OfferMajority
Pfenex

target

Pfenex

Ligand Pharmaceuticals

bidder

Ligand Pharmaceuticals

£349m

13 dealmakers

United Kingdom
Biotechnology
PrivateMajorityCross BorderAcquisition
Vernalis (research & Development Unit)

target

Vernalis (research & Development Unit)

Hitgen

bidder

Hitgen

£19m

5 dealmakers

United States
Biotechnology
AcquisitionPrivateMajorityDomestic
GENEDX

target

GENEDX

SEMA4

bidder

SEMA4

£455m

34 dealmakers

United States
Biotechnology
Spin OffAcquisitionMajorityDomesticPrivateDe-SPACPrivate EquityReverse Takeover
Omniab

target

Omniab

Avista Public Acquisition Corp Ii

bidder

Avista Public Acquisition Corp Ii

£643m

36 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US